These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6098236)

  • 21. Carboxy-terminal regions of the sarcoplasmic/endoplasmic reticulum Ca(2+)- and the Na+/K(+)-ATPases control their K+ sensitivity.
    Ishii T; Hata F; Lemas MV; Fambrough DM; Takeyasu K
    Biochemistry; 1997 Jan; 36(2):442-51. PubMed ID: 9003197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Na,K-ATPase alpha 2 inhibition alters calcium responses in optic nerve astrocytes.
    Hartford AK; Messer ML; Moseley AE; Lingrel JB; Delamere NA
    Glia; 2004 Feb; 45(3):229-37. PubMed ID: 14730696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K+ and NH4(+) modulate gill (Na+, K+)-ATPase activity in the blue crab, Callinectes ornatus: fine tuning of ammonia excretion.
    Garçon DP; Masui DC; Mantelatto FL; McNamara JC; Furriel RP; Leone FA
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):145-55. PubMed ID: 17276114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration in ouabain-sensitive sodium potassium pump of erythrocytes during pregnancy induced hypertension: a kinetic study.
    Kaur G; Kapoor N; Mohan P; Sri Nageswari K; Singh MJ; Prasad R
    J Biochem Mol Biol Biophys; 2002 Jun; 6(3):163-6. PubMed ID: 12186749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct demonstration of an inhibitor of sodium, potassium dependent adenosine triphosphatase (Na+, K+-ATPase) in plasma from normotensive and hypertensive subjects.
    Roulston JE; Traill K; Wathen CG
    Clin Chim Acta; 1986 Sep; 159(2):163-71. PubMed ID: 3021362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive assay and kinetic property of urinary inhibitor of Na+, K+-ATPase in sodium-loaded patients with essential hypertension.
    Masugi F; Ogihara T; Hasegawa T; Imai N; Nagano M; Tabuchi Y; Kumahara Y
    Jpn Circ J; 1985 Sep; 49(9):980-3. PubMed ID: 2999460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ
    Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
    [No Abstract]   [Full Text] [Related]  

  • 29. Sodium activation of heart (Na+ + K+)-ATPase from normotensive and spontaneously hypertensive rats.
    Godfraind T; Noël F
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):139-44. PubMed ID: 6250502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual variability in membrane sodium transport during salt loading--evidence against the production of a Na+-K+-ATPase inhibitor in hypertension.
    Maling TJ; Siebers RW
    Prog Biochem Pharmacol; 1988; 23():91-100. PubMed ID: 2847194
    [No Abstract]   [Full Text] [Related]  

  • 32. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous sodium-potassium pump inhibitor in low renin hypertension.
    Haddy FJ; Pamnani MB
    Prog Clin Biol Res; 1985; 192():205-12. PubMed ID: 3001753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endogenous cytochemically assayable Na-K-ATPase inhibitor and its relation to hypertension.
    de Wardener HE; Millet J; Holland S; MacGregor G; Alaghband-Zadeh J
    Klin Wochenschr; 1987; 65 Suppl 8():4-7. PubMed ID: 3599801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
    Nirasawa Y; Temma K; Fink GD; Akera T
    Life Sci; 1985 Aug; 37(8):767-74. PubMed ID: 2991692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Na+/K+-dependent adenosinetriphosphatase in rabbit kidney. Separation by affinity chromatography.
    Giunta C; De Bortoli M; Brigidi R
    Boll Soc Ital Biol Sper; 1979 Sep; 55(17):1659-65. PubMed ID: 233068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plasma inhibitor of sodium and potassium activated adenosine triphosphatase in patients with essential hypertension.
    Toriyabe S; Miura Y; Kimura S; Meguro Y; Sugawara T; Noshiro T; Takahashi M; Ohashi H; Sano N; Watanabe H
    Tohoku J Exp Med; 1988 Jun; 155(2):129-37. PubMed ID: 2850642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects.
    Gallice PM; Kovacic HN; Brunet PJ; Berland YF; Crevat AD
    Clin Chim Acta; 1998 May; 273(2):149-60. PubMed ID: 9657345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):618-22. PubMed ID: 1651740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.